【摘要】 目的分析艾滋病抗病毒治疗(ART)病例的死亡情况,探讨相关影响因素。方法对河北省2004-2013年死亡的艾滋病ART病例资料进行回顾性总结分析。结果截至2013年12月31日,共有229例治疗病例死亡,71.2%死于艾滋病相关疾病。男性病例占62.4%;40～49岁组病人占38.9%;经血途径感染者占40.6%,经性途径感染者占52.0%;农民占64.6%;初中及以下占81.2%;已婚或同居有配偶者占66.4%。40.2%的病例治疗前CD+4T淋巴细胞(简称CD4细胞)计数<50个/μL,且其中50%病例在3个月内死亡;而治疗前CD4细胞计数>200个/μL的病例占死亡总数13.5%,仅22.6%在3个月内死亡。经血液途径感染者中,69.9%的病例生存时间超过3个月,经性途径感染的病例中,50.4%在3个月内死亡。结论治疗延迟是导致艾滋病病人死亡的主要原因,早期治疗能降低艾滋病病死率。更多还原

【Abstract】 Objective To explore influence factors by analyzing the death causes of AIDS patients receiving antiretroviral treatment.Methods A retrospective analysis was performed in death patients receiving antiretroviral treatment in Hebei Province from 2004 to 2013.Results Up to December 31,2013,there were 229 death patients,with 72.1%died of AIDS related diseases.Male patients accounted for 62.4%,patients of 40-49 years old 38.9%,patients transmitted through blood 40.6%,patients through sexual transmission 52.0%,farmers 64.6%,patients at level of junior high school and below 81.2%,and married or cohabiting spouses 66.4%.The patients with CD4 cell counts less than 50cells/μL accounted for 40.2%at baseline,and 50%patients died in 3months.The patients with CD4 cell counts higher than 200cells/μL accounted for 13.5%,and only 22.6% died within 3months.Patients transmitted by blood with survival time more than 3months accounted of 69.9%,while 50.4% of sexually transmitted patients died within 3months.Conclusion Delayed treatment was the primary cause of death,and an earlier treatment would decrease the death rate.更多还原